James M G Larkin

35PUBLICATIONS
299CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsEpidemiological modellingCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 21, 2026
Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.

|Sep 04, 2026
Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy.

|Mar 20, 2026
CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer.

Francesca Jackson-Spence, James Larkin, Poulam Patel

|Jan 21, 2026
Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing.

Richard Culliford, Charlie Mills, Daniel Chubb

|Aug 27, 2025
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma.

Dawn Lee, Zain Ahmad, James M G Larkin

|Jun 02, 2025
Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.

Theresa Medina, Jason A Chesney, Harriet M Kluger

Pageof 6

Frequent Collaborators

12 joint publications

Paolo Antonio Ascierto

11 joint publications

Georgina V Long

11 joint publications

Jean-Jacques Grob

8 joint publications

Dirk Schadendorf